From visions of global leadership to an asset sale: where did it go wrong for Althea’s medical aspirations? by Steve Jones May 8, 2025May 8, 2025 With Althea calling time on its Australian pharma business and selling the assets to Tasmanian Botanics, […]
Tasmanian Botanics to ‘breathe new life’ into Althea brand as it snaps up pharma assets for $1 million by Martin Lane and Steve Jones May 7, 2025May 8, 2025
Althea considers exiting medicinal cannabis market amid sales collapse by Steve Jones April 30, 2025April 30, 2025
Althea blames medical sales decline on TGA ‘falling asleep at the wheel’ amid ‘crazy’ antics of competitors by Steve Jones March 21, 2025March 26, 2025
Althea claims profitability ‘is close’ despite pharmaceutical nosedive by Steve Jones March 3, 2025March 4, 2025
Changes on the horizon but exit of pharmaceutical market ‘not currently on the table’, says Althea CEO by Steve Jones February 20, 2025February 20, 2025
Althea slashes revenue guidance and sales forecast, scraps vape project by Steve Jones February 13, 2025February 13, 2025
Althea resumes trading on ASX as board narrowly avoids a second shareholder revolt by Steve Jones February 3, 2025February 3, 2025
Althea set for court this week after detecting 14 breaches of ASX rules by Steve Jones January 28, 2025January 28, 2025
